Delivery Order SPE2DB24D1104-SPE2DB25FYDV2
- Not listed
- The Defense Logistics Agency awarded a $8,453.04 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Durolane 60 mg/3 mL syringes. This firm fixed-price contract, with a completion date of July 29, 2025, represents a competitively awarded non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $10,520.07 delivery order to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes. This is a firm fixed price contract with an ultimate completion date of July 28, 2025, representing a non-set-aside procurement awarded competitively on July 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $6,112.30 delivery order to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract requires performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a non-set-aside procurement action for this injectable pharmaceutical product used in joint pain treatment and osteoarthritis management. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,347.52 by the Defense Logistics Agency on August 1, 2025, for Durolane 60 mg/3 mL syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance is scheduled for completion by August 4, 2025, with work to be performed at the contractor's Conshohocken facility. This delivery...
- The Defense Logistics Agency awarded a $3,523.79 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Durolane 60 mg/3 mL syringes. This non-set-aside, firm fixed-price contract is scheduled for completion by August 12, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply requirements for military and defense healthcare...
- The Defense Logistics Agency awarded a $5,972.71 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 60 mg/3 ml syringes of Durolane. The delivery order was issued under an existing Amerisourcebergen indefinite-delivery/indefinite-quantity contract vehicle and calls for shipment of the specified pharmaceutical product to a location in Conshohocken, Pennsylvania. Performance is required from July 21-24, 2023. As the DLA supports military medical supply needs, this delivery...
- This is a $3,180.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide DUROLANE 60 MG/3 ML SYRINGE 3ML medical supplies. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,161.40 firm fixed price contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product. This award does not have a set-aside designation. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The $4,457.82 contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a performance period ending on March 12, 2025. The contract is a Firm Fixed Price (FFP) arrangement. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYDV2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $5.4K. This is a firm fixed price delivery order with an ultimate completion date of July 30, 2025, and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies pharmaceutical products and medical supplies to support military healthcare systems and other government agencies, including the Defense Health Agency and U.S. Coast Guard. The Durolane product being delivered is an injectable hyaluronic acid-based treatment commonly used for joint pain management, consistent with the company's portfolio of specialty medications and pain management pharmaceuticals supplied through the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 7/29/25 |